Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank0
3Y CAGR-37.6%
5Y CAGR-25.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
-37.6%/yr
vs +12.6%/yr prior
5Y CAGR
-25.6%/yr
Recent deceleration
Acceleration
-50.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.30M | -56.5% |
| 2024 | $30.60M | -30.6% |
| 2023 | $44.10M | -19.5% |
| 2022 | $54.80M | -10.9% |
| 2021 | $61.50M | +5.8% |
| 2020 | $58.15M | -0.6% |
| 2019 | $58.50M | +71.5% |
| 2018 | $34.12M | -50.8% |
| 2017 | $69.30M | -14.9% |
| 2016 | $81.43M | - |